Phase II data on Lp(a) lowering, followed by NHLBI recommendation - PACE-CME

Phase II data on Lpa lowering followed by NHLBI recommendation

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

Lp(a) and immune metabolism
Lp(a) and immune metabolism
The Imminent danger of Lp(a): Time to face to challenge
Lp(a) and immune metabolism
- Jeffrey Kroon, PhD
Lp(a) and calcification in aortic stenosis
Lp(a) and calcification in aortic stenosis
The Imminent danger of Lp(a): Time to face to challenge
Lp(a) and calcification in aortic stenosis
- Kang He Zheng, MD
Lp(a) apheresis and CVD risk modulation
Lp(a) apheresis and CVD risk modulation
The Imminent danger of Lp(a): Time to face to challenge
Lp(a) apheresis and CVD risk modulation
- Elisa Waldmann, MD
Entry of Lp(a) into the CV arena
Entry of Lp(a) into the CV arena
The Imminent danger of Lp(a): Time to face to challenge
Entry of Lp(a) into the CV arena
- Prof. Florian Kronenberg, MD